Articles by The Uromigos
Dr. Powles chaired a livestreamed RCC session that included lively discussion from Drs. Atkins, McDermott, and Rini.
The panel highlights a serious of relevant studies in renal cell carcinoma, including CONTACT-03 and TiNivo-2.
The panel discusses data related to RLTs in prostate cancer, including a recap of the VISION trial and the PSMAfore trial.
The panel breaks down the details of the PROpel, TALAPRO-2, and MAGNITUDE trials along with relevant rPFS and HR data.
The panel discussed the latest updates in NMIBC, including relevant data pertaining to pembro, atezo, and more.
The panel discussed the latest data and updates in frontline bladder cancer during a livestreamed session.
Tian Zhang joins the podcast to give an overview of some of the panels presented at this year's IKCS meeting.
In the final round of The Uromigos Cup, Team Cleveland battled Team LA to determine who would take home the coveted trophy.
The second round of The Uromigos Cup featured Team Cleveland versus Team NYC to see who would move on to the final round.
The first round of The Uromigos Cup featured Team Boston versus Team LA in genitourinary oncology-based trivia.
Monty Pal, Toni Chouieri, and Tian Zhang join Tom and Brian to discuss CONTACT-03, TiNivo-2, IO-based therapy, and more.
Brian is joined by Drs. Agarwal, Dorff, McKay, and Morris to review the state of radioligand therapy.
Tom is joined by Drs. Chang, Daneshmand, and Grivas to discuss new therapies in NMIBC and BCG-refractory NMIBC.
Silke Gillessen, MD, PhD recaps some of the kidney, bladder, and prostate cancer data from this year's ESMO meeting.
Brian and Tom give details on the various panels that will take place at The Uromigos Live & Unplugged 2023.
Dr. Kevin Kelly discusses the AMG509 phase 1 study of xaluritamig, a bispecific T cell engager, for prostate cancer.
Xinan Sheng, MD, joins the podcast to discuss the RENOTORCH trial on toripalimab plus axitinib for advanced RCC.
Drs. McKay, Gupta, and more talk about the best moments from last year's Uromigos Live & Unplugged event.
Michiel Van der Heijdan, MD, PhD, discusses EV-302 and CheckMate-901 on EV plus pembrolizumab and nivolumab plus ipilimumab.
Yohann Loriot, MD, PhD, gives an update on the use of erdafitinib within the THOR randomized phase 3 trial.
630 Madison Ave.
Manalapan, NJ 07726
© 2023 Mashup Media, LLC. All rights reserved.